TCG Crossover (TCG X), in partnership with The Column Group, has raised an inaugural USD824 million fund focused on crossover and public investments in the life sciences.
The oversubscribed fund attracted an array of premier investors including university endowments, family offices, pension funds and sovereign wealth funds.
TCG X is led by Founding Managing Partner, Dr Chen Yu, formerly a Managing Partner at Vivo Capital. Dr Yu is joined by a founding team of seasoned investors from across the life sciences sector while it expects to add additional investment staff in the months to come:
- Cariad Chester, former Managing Director at Aquilo Capital
- Ryuk Byun, former Senior Associate at Aisling Capital
- Giuliano Marostica, former Senior Associate at Great Point Partners
Read more at Private Equity Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.